Long term survival after acute myocardial infarction in Australia and New Zealand, 2009-2015: a population cohort study.

Objective: To assess long term survival and patient characteristics associated with survival following acute myocardial infarction (AMI) in Australia and New Zealand.

Design: Cohort study.

Setting, Participants: All patients admitted with AMI (ICD-10-AM codes I21.

Biomaterial strategies to improve the efficacy of bone marrow cell therapy for myocardial infarction.

The feasibility and safety of bone marrow cell (BMC) therapy for cardiac repair following myocardial infarction has been demonstrated in clinical studies, albeit with relatively modest structural and functional benefits. In response to the shortcomings of BMC therapy, the use of biomaterials to enhance cell transplantation is being investigated. Areas covered: The authors first review what has been learned from BMC therapies for the treatment of myocardial infarction in animal models and in clinical trials.